News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,997 Results
Type
Article (76467)
Company Profile (645)
Press Release (752864)
Multimedia
Podcasts (154)
Webinars (24)
Section
Business (228198)
Career Advice (3785)
Deals (39246)
Drug Delivery (132)
Drug Development (89486)
Employer Resources (200)
FDA (17977)
Job Trends (17165)
News (388757)
Policy (38929)
Tag
Academia (3001)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56290)
ALS (129)
Alzheimer's disease (1631)
Antibody-drug conjugate (ADC) (197)
Approvals (17961)
Artificial intelligence (407)
Autoimmune disease (38)
Automation (22)
Bankruptcy (403)
Best Places to Work (12632)
BIOSECURE Act (22)
Biosimilars (143)
Biotechnology (441)
Bladder cancer (111)
Brain cancer (45)
Breast cancer (423)
Cancer (3376)
Cardiovascular disease (286)
Career advice (3231)
Career pathing (34)
CAR-T (224)
CDC (43)
Cell therapy (605)
Cervical cancer (27)
Clinical research (73438)
Collaboration (1219)
Company closure (4)
Compensation (809)
Complete response letters (44)
COVID-19 (2928)
CRISPR (72)
C-suite (450)
Cystic fibrosis (128)
Data (3481)
Decentralized trials (2)
Denatured (54)
Depression (88)
Diabetes (396)
Diagnostics (7019)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (180)
Drug pricing (167)
Drug shortages (36)
Duchenne muscular dystrophy (175)
Earnings (96054)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (131099)
Executive appointments (942)
FDA (20113)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1078)
Gene editing (155)
Generative AI (37)
Gene therapy (480)
GLP-1 (974)
Government (5299)
Grass and pollen (7)
Guidances (328)
Healthcare (20918)
HIV (46)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (201)
Immuno-oncology (17)
Indications (44)
Infectious disease (3137)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (82)
Intellectual property (150)
Interviews (743)
IPO (17811)
IRA (59)
Job creations (4979)
Job search strategy (2629)
Kidney cancer (14)
Labor market (66)
Layoffs (614)
Leadership (30)
Legal (9950)
Liver cancer (88)
Longevity (12)
Lung cancer (474)
Lymphoma (243)
Machine learning (16)
Management (65)
Manufacturing (515)
MASH (113)
Medical device (14782)
Medtech (14796)
Mergers & acquisitions (22230)
Metabolic disorders (1025)
Multiple sclerosis (109)
NASH (23)
Neurodegenerative disease (170)
Neuropsychiatric disorders (49)
Neuroscience (2470)
NextGen: Class of 2025 (7641)
Non-profit (5094)
Now hiring (54)
Obesity (520)
Opinion (300)
Ovarian cancer (110)
Pain (140)
Pancreatic cancer (139)
Parkinson's disease (208)
Partnered (25)
Patents (368)
Patient recruitment (231)
Peanut (55)
People (64789)
Pharmaceutical (132)
Pharmacy benefit managers (25)
Phase I (22666)
Phase II (32013)
Phase III (24144)
Pipeline (2348)
Policy (272)
Postmarket research (3283)
Preclinical (10060)
Press Release (72)
Prostate cancer (164)
Psychedelics (48)
Radiopharmaceuticals (278)
Rare diseases (579)
Real estate (7171)
Recruiting (76)
Regulatory (26821)
Reports (64)
Research institute (2664)
Resumes & cover letters (590)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (180)
Series B (130)
Service/supplier (27)
Sickle cell disease (73)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (38)
Startups (4214)
State (2)
Stomach cancer (17)
Supply chain (89)
Tariffs (81)
The Weekly (98)
Vaccines (981)
Venture capital (63)
Weight loss (358)
Women's health (52)
Worklife (20)
Date
Today (52)
Last 7 days (540)
Last 30 days (2546)
Last 365 days (33462)
2025 (21906)
2024 (37916)
2023 (42567)
2022 (53928)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39098)
2017 (36856)
2016 (37795)
2015 (43821)
2014 (38556)
2013 (34692)
2012 (36543)
2011 (36597)
2010 (36130)
Location
Africa (1206)
Alabama (75)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (49114)
Australia (8424)
California (8599)
Canada (2623)
China (803)
Colorado (365)
Connecticut (383)
Delaware (233)
Europe (111864)
Florida (1281)
Georgia (295)
Hawaii (3)
Idaho (66)
Illinois (760)
India (42)
Indiana (418)
Iowa (19)
Japan (256)
Kansas (120)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1187)
Massachusetts (6513)
Michigan (287)
Minnesota (527)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (96)
New Hampshire (75)
New Jersey (2380)
New Mexico (31)
New York (2354)
North Carolina (1318)
North Dakota (10)
Northern California (3805)
Ohio (272)
Oklahoma (17)
Oregon (47)
Pennsylvania (1817)
Puerto Rico (18)
Rhode Island (42)
South America (1573)
South Carolina (43)
South Dakota (1)
Southern California (3240)
Tennessee (137)
Texas (1335)
United States (32024)
Utah (256)
Virginia (232)
Washington D.C. (82)
Washington State (735)
West Virginia (4)
Wisconsin (88)
829,997 Results for "merck and co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Merck’s $3B Savings Push Claims 6,000 Jobs
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth areas of its business.
August 1, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results
July 29, 2025
·
19 min read
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
In the second biggest acquisition of the year, Merck gains the commercial COPD drug Ohtuvayre, which could help offset the loss of revenue when Keytruda’s patent expires later this decade.
July 9, 2025
·
2 min read
·
Tristan Manalac
Cancer
Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Merck’s Welireg
Updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug secured approval for a type of kidney cancer in 2023.
June 2, 2025
·
2 min read
·
Nick Paul Taylor
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest rejection reportedly driven by FDA’s top cancer regulator Richard Pazdur; Merck’s $3 billion savings push claims 6,000 jobs; and Pfizer CEO Albert Bourla addresses President Donald Trump’s new threats around Most Favored Nation drug pricing.
August 6, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Merck to Participate in the 2025 Wells Fargo Healthcare Conference
August 29, 2025
·
3 min read
Job Trends
July Layoffs Skyrocket 487% YOY With Merck Cuts
The number of biopharma professionals let go has increased year over year for three straight months. In July, as many as 8,000 people lost or were projected to lose their jobs, due largely to news that Merck projects to cut roughly 6,000 employees as part of a multiyear process.
August 5, 2025
·
4 min read
·
Angela Gabriel
Regulatory
FDA Action Alert: GSK, Sanofi, Merck and More
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s oral cancer drug for a pair of rare tumors.
May 5, 2025
·
6 min read
·
Tristan Manalac
Cancer
Merck’s Injectable Keytruda Matches IV Formula in Pivotal Trial
Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
Neuroscience
Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech
Waltham, Massachusetts–based Skyhawk Therapeutics has been collecting collaborations with larger companies in spades since launching in 2018.
August 18, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 83,000
Next